CH Biotech R&D Co., Ltd. (TPE:6534)
113.00
+1.00 (0.89%)
Sep 30, 2025, 1:30 PM CST
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 11.62 billion as of September 30, 2025. Its market cap has increased by 49.67% in one year.
Market Cap
11.62B
Enterprise Value
11.88B
Revenue
1.68B
Ranking
n/a
PE Ratio
32.03
Stock Price
113.00
Market Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 11.62B, an increase of 55.51%. That is a compound annual growth rate of 4.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 11.62B | 39.85% |
Dec 31, 2024 | 8.31B | 0.37% |
Dec 29, 2023 | 8.28B | 13.05% |
Dec 30, 2022 | 7.32B | 42.15% |
Dec 30, 2021 | 5.15B | 20.79% |
Dec 31, 2020 | 4.26B | -25.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nan Ya Plastics | 312.87B |
China Steel | 297.98B |
Formosa Plastics | 245.40B |
TCC Group Holdings | 180.75B |
Formosa Chemicals & Fibre | 171.38B |
Asia Cement | 131.75B |
Walsin Lihwa | 111.00B |
Ta Chen Stainless Pipe | 82.11B |